“Device manufacturers and stakeholders, including biopharma companies, healthcare providers, payers and patients, have realised the benefits and importance of training prior to initial self-injections, continuous training and onboarding throughout disease management to counteract administration training decay, and ultimately the role of training and onboarding to help improve adherence and health outcomes.”
Simulating Self-Injection Through Training Improves Patient Onboarding
Although there are many positive changes impacting self-injecting patients, there are also some challenges patients and other stakeholders face, including training decay from lengthy gaps between self-administration, forgetfulness of dosing regime, and fear of the actual injection sensation due to conditioning degradation, explains Joe Reynolds, Research Manager, Design & Engineering, Noble. “These factors could increase the risk of errors and contribute to lower adherence rates for self-injecting patient populations.”
Joe Reynolds outlines the increasing range of options available for helping patients learn how to use their devices
Pulmonary drug delivery is one of the most common routes of administration for chronic and acute conditions, such as chronic obstructive pulmonary disease (COPD) and severe asthma. As with any device-delivered therapy, the successful use of pulmonary delivery systems depends on a number of intrinsic and extrinsic variables, including the properties of the lung, breathing patterns and delivery techniques.
Noble is featured in Andrew Dunning's article about technological advancements in the healthcare system
Poor patient compliance and adherence cost the healthcare system more than $564 billion annually. It is important that pharmaceutical brands and healthcare providers (HCPs) leverage technology to help reduce primary non-adherence, also known as Rx abandonment and improve adherence to treatment at a patient’s initial diagnosis. To accomplish this, more brands are embracing patient-centric technology as a marketing strategy. An influx of new biologic and biosimilar medications are about to hit the market, making patient-centric technology programs an impactful marketing strategy for brands looking to stand out from the competition. Brands are leveraging these technologies to streamline patient access to complex drug therapies, correctly train patients on how to administer treatment, and engage with patients through mobile applications.
Craig Baker provides insight on the challenges and opportunities in the Pharma industry regarding combination products
Combination products are products that combine two or more different types of FDA-regulated products, including drugs, biologics, and medical devices. Regulators are working to make this process easier with the establishment of the Combination Product Council, identifying process improvements, and facilitating communication between agency centers. Combination therapies are a natural outgrowth to the evolution of [...]
Joe Reynolds provides insights regarding HOW DEVICE training CAN HELP IMPRove adherence
Over the years, many industry stakeholders and pharmaceutical manufacturers have come to realize the importance of training and the role it has on promoting healthy patient outcomes and effective disease management. Many studies suggest that without proper training during the onboarding process, or the first 30 to 90 days of treatment, patients are more likely to drop off from therapy or incorrectly use drug delivery devices, such as autoinjectors, prefilled syringes, and other forms of self-administration.
Joe Reynolds featured article in ONdrugDelivery
Noble's Research Manager outlines some of the fundamental principles and benefits of training devices in the context of prefilled syringes and highlights some specific training device technologies including novel needle simulators and angle aids.
Craig Baker provides insights on future trends of the combination product industry including opportunities for competitive differentiation and brand loyalty
The global injectable drug delivery devices market is expected to increase from around $11.6 billion in 2013 to around $ 17.5 billion in 2018.1 Growth is being attributed to the rising prevalence of chronic diseases, the biologics market, technological advancements, and demand for self-injection devices, which are expected to experience the highest growth rate of 16.1%.
Paul Sullivan explains the implementation of patient support training materials to coincide with brand launches
Product launch is a critical moment in a brand’s ultimate success. Product launches for pharmaceuticals are complex and differ in many ways from other industries, with multiple key players such as research and development, formulation specialists, analysts, regulatory affairs, device engineers, commercial/brand teams, and many others intimately involved. This process takes on additional complexity with combination products—generally, drug-device combinations such as prefilled syringes, inhalation devices and the like.
Joe Reynolds describes how device trainer packaging can assist in patient onboarding and adherence
As research manager in Noble’s design and engineering department, Reynolds helps drug and medical device manufacturers develop training aids that can help patients learn how to self-administer therapies. Some of these aids can be incorporated into packaging, and they could provide additional support when patients experience situations such as needle anxiety or training decay.
Mike Siemer explains the design complexities and brand and patient benefits of developing autoinjector trainers
Autoinjectors have become the main drug delivery devices of choice due to their ability to simplify the number of steps required for injection. However, many patients make mistakes using the devices such as not holding the device correctly or not keeping it in place for long enough. Mike Siemer, Director of Design and Engineering at Noble reports on the development of training devices that replicate the design and operation of the autoinjectors so patients can better understand how to use them.
Paul Sullivan provides insights on the future of the prefilled syringe market
Special Feature begins on page 39.
The demand for prefilled syringes continues to grow as more patients are being required to self-administer medications, such as the increasing number of biologics and biosimilars entering the market. As these products continue to augment and launch into new therapeutic sectors, training and education will remain a critical success factor that will determine a patient’s ability to safely and effectively use prefilled syringes and adhere to therapy, explains Paul Sullivan, Associate Director of Business Development at Noble.
Chris Evans, reveals how West recently announced a collaboration with Noble to develop validated training solutions for self-injection systems
Several biologics coming onto the market offer the potential to make a difference in the lives of patients with incurable-but-controllable conditions such as diabetes and Crohn’s disease. These innovative therapeutics aim to improve patients’ quality of life by not only reducing symptoms, but also offering new independence enabled by at-home treatment.
Craig Baker shares his thoughts on patient-friendly, self-injection delivery systems and the importance of patient education and training
Unit shipments for wearable devices were expected to drive about $32 billion in revenue by 2019 — more than three times the $10 billion in revenue the market saw in 2013, according to a 2015 IHS Technology white paper on the wearables market. Beside the business applications IHS identified, it also focused on consumer possibilities in the wearables market — as fitness trackers, health data collectors and beyond.
Noble's company profile as featured in ONdrugDELIVERY
Noble®, the leader in onboarding and device training, is a full-service, patient-centred product development and manufacturing company. Noble works closely with the world’s leading pharmaceutical and biotechnology companies to develop educational and training solutions designed to provide positive patient onboarding experiences, reduce errors and improve patient outcomes. Cross-disciplinary designers and engineers provide fully customised solutions from the first concept sketch through to production, in both regulated and non-regulated environments. ISO 9001 and ISO 13485 supply chain and manufacturing.
Mike Siemer's featured article in Medical Product Outsourcing
The process of 3D printing has impacted many industries by making the development and prototyping stages quicker, more cost-effective, and efficient. One industry that has seen the largest impact is the health and medical sector, specifically the pharmaceutical device space. Rapid prototyping and 3D printing techniques offer the ability to get these complex devices to market quickly. A prototyping process that previously took several months or even years can now be completed in just days.
Jeff Miller's featured article in Pharmaceutical Manufacturing and Packaging Sourcer
As patients are increasingly being prescribed complex drug therapies via self-administered drug delivery devices, compliance and usage challenges can occur. Is better patient training the answer to improved treatment management?
Paul sullivan and craig baker discuss RESPIRATORY device training as featured in OnDrugDeliverY
Here, Paul Sullivan, Associate Director, Business Development, and Craig Baker, Executive Vice-President, both of Noble, provide data from recent patient studies to emphasise the importance of training devices in improving adherence to, and compliance with, inhaled therapeutics.